Youth who underwent metabolic and bariatric surgery as teenagers are at heightened risk for alcohol use, according to the first study to document long-term alcohol use and associated issues in this population. Researchers found that after eight years, nearly half of the study participants ha
Sharing an update on patients admitted after consuming spurious liquor, Dr Sanjay Kumar from the Primary Health Centre on Thursday said, "A total of 47 people were admitted here. Of them, some with minor symptoms were treated and discharged. Many had effects on vision due to toxins. Treatmen
The symptoms of depression in adolescents, say experts, can differ from the adult population with adolescents tending to have more frequently somatic symptoms, anxiety, disruptive behaviour and personality disorders
Alzheimer's disease (AD) is the fifth leading cause of death in adults over 65 years old. While many potential treatments for neurodegenerative disease focus on developing drugs to target key culprits, a relatively new approach aims to treat the brain.
Endometriosis is a condition that causes pelvic pain, menstrual cramps, and infertility, and it affects up to 15 percent of women in the United States who are of reproductive age. Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. This tumour ma
In animal models, researchers revealed how water enriched with hydrogen molecules (H2) reduces the symptoms of neuropathic pain and its associated emotional disorders.
Oregon Health & Science University researchers and partners are developing what could become the first-ever treatment against the debilitating joint pain that can last months or years after becoming infected with the emerging Chikungunya virus.
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab--a novel, patient-tailored monoclonal antibody therapy--showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers report
A new study in the journal Nature Communications reveals how a viral toxin produced by the SARS-CoV-2 virus may contribute to severe COVID-19 infections. The study shows how a portion of the SARS-CoV-2 "spike" protein can damage cell barriers that line the inside of blood vessels within orga
When compared to those who have not been vaccinated, those who have recovered from a coronavirus infection have a halved risk of becoming infected a second time or contracting COVID-19 again with severe symptoms.